Search Results - clinical specialty > neurology

5 Results Sort By:
Gene Transfer to Improve Cognitive Dysfunction in Alzheimer’s Disease
University of Texas Health Science Center at San Antonio researchers have developed a unique therapeutic approach which could restore learning and memory ability in those afflicted with Alzheimer’s Disease and other neurodegenerative diseases. Abnormalities in the expression of cAMP-response element binding protein (CREB) have been reported in...
Published: 1/16/2019   |   Inventor(s): Salvatore Oddo, Antonella Caccamo
Category(s): Clinical Specialty > Neurology, Therapeutics > Small Molecule
Micro-RNA Therapy for High-Risk Pediatric Brain Cancer
A MicroRNA therapy has been developed for the purpose of increasing the chemo- and radio-sensitivity of tumor cells in Medulloblastoma. The invention would allow for lower dosages of radiation and chemotherapy by working synergistically with these therapies, thus reducing adverse side effects. It may also lead to more complete eradication of the tu...
Published: 9/25/2018   |   Inventor(s): Manjeet Rao, Nourhan Abdelfattah
Category(s): Therapeutics > Biologics, Therapeutics > Nucleic Acids, Clinical Specialty > Neurology, Clinical Specialty > Oncology, Clinical Specialty > Pediatrics
Glow Bright
Small, fluorescent surgical disposables (i.e. needles, sutures, and trocars) have been invented by UT Health SA that fluoresce to aid in visualization of the item. This functionality can be used in the event that the items are lost or unaccounted for during or after a surgical procedure. Background:Losing an instrument during surgery is a rare but...
Published: 9/20/2018   |   Inventor(s): Kinley Beck, Jeong-Hyeon Sohn, Petar Yanev, Joshua Iltis
Category(s): Clinical Specialty > Opthamology, Medical Devices > Consumables, Medical Devices > Surgical Equipment, Clinical Specialty > Neurology
Antipsychotic Drugs to Reduce the Abuse Liability of Opioids
This invention is a novel use of “atypical” antipsychotic drugs in combination with opioids to reduce the abuse potential of the opioid pain medication. The abuse potential is reduced by inhibiting the stimulation of the reward center in the brain.Background:The global pain market is estimated to reach $21.6 billion USD in 2022 and an e...
Published: 8/14/2018   |   Inventor(s): Daniel Lodge, Alan Frazer
Category(s): Clinical Specialty > Neurology, Clinical Specialty > Pain Management, Therapeutics > Analgesics
Intravenous Tramadol for Treatment of anti-NMDA Encephalitis
The invention is a combinatorial therapy used to enhance the efficacy of plasma exchange (PLEX) in treating patients with anti-NMDAR encephalitis. This treatment regimen would treat both the psychiatric and immunological manifestations of this disorder and substantially lower the patients’ recovery periods. Background:Anti-NMDAR encephalitis ...
Published: 4/20/2018   |   Inventor(s): Ali Seifi
Category(s): Therapeutics > Small Molecule, Clinical Specialty > Neurology, Clinical Specialty > Oncology, Clinical Specialty > Immunology